Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Sales | 387 | 289 | 140 | 611 | 622 |
| Gross Profit | 387 | 289 | 140 | 611 | 622 |
| Operating Expenses | 6,535 | 10,183 | 8,419 | 6,269 | 5,218 |
| Operating Income | -6,148 | -9,894 | -8,279 | -5,659 | -4,596 |
| Interest Expense | 224 | 238 | 174 | 160 | 160 |
| Other Income | 70 | 18,036 | -391 | -1,181 | -798 |
| Pre-tax Income | -6,303 | 7,903 | -8,844 | -7,000 | -5,554 |
| Net Income Continuous | -6,303 | 7,903 | -8,844 | -7,000 | -5,554 |
| Net Income | $-6,303 | $7,903 | $-8,844 | $-7,000 | $-5,554 |
| EPS Basic Total Ops | -1.52 | 2.40 | -2.20 | -2.00 | -1.88 |
| EPS Basic Continuous Ops | -1.53 | 2.37 | -2.18 | -2.00 | -1.87 |
| EPS Diluted Total Ops | -1.52 | 2.40 | -2.20 | -2.00 | -1.88 |
| EPS Diluted Continuous Ops | -1.53 | 2.37 | -2.18 | -2.00 | -1.87 |
| EBITDA(a) | $-5,887 | $-9,690 | $-8,093 | $-5,478 | $-4,421 |